March 2024: Revolution in Diabetes, Painless Smartpatch

Medicsen revolutionizes diabetes treatment with a painless Smartpatch.

Image credits: Medicsensors S.L

In the ever-evolving field of healthcare technology, Medicsen emerges as a bold innovator, shaping the future for people living with diabetes. Driven by the desire to eliminate the pain and inconvenience associated with traditional diabetes management, Medicsen has developed a revolutionary solution: the Medicsen Smartpatch.

Imagine, a world where managing diabetes is painless, discreet, and personalized. The Medicsen Smartpatch makes this vision a reality. This needle-free, wearable device acts as a smart companion, simulating the functions of the pancreas and delivering essential medications directly through the skin.

Utilizing harmless waves, the Smartpatch painlessly opens natural skin pores, allowing macromolecules like insulin and heparin to enter the body. This innovative technology ensures maximum comfort and discretion, tucked away in a small, wearable device.

Image credits: Medicsensors S.L

About Medicsen

Medicsen was founded in 2023 and has quickly developed into an award-winning start-up in the field of medical technology. The company specializes in pain-free drug delivery through the skin and wearable devices for patients with chronic diseases. The company focuses on developing user-friendly and pain-free solutions for a better quality of life.

Sam Draper
March 1, 2024

March 2024

Innovation of the Month

Do you want to discover more, visit the website
Visit Website

Other news

Scientists Take Inspiration from Octopus to Create Wearable Biosensor that Sticks to Wet and Dry Skin

Scientists often take inspiration from nature when developing new materials.

Sarcos Robotics Unveils Alpha Version of its Guardian XO Full-Body Industrial Exoskeleton

Sarcos Robotics, an American developer of robotics and microelectromechanical systems...

Healthtech Startup Ultrahuman Raises $17.5M In Series B Funding

Health technology startup Ultrahuman has raised $17.5 million in series B funding round backed ...

January 2024: Hydrogel-Free Flexcon® Omni-Wave™ for Biosensing

Dry electrode technology saves time and money for manufacturers while improving patient comfort!
Discover more